Description of the Two-Dimensional Layer-Specific Strain Echocardiography Phenotype of Arrhythmogenic Left Ventricular Cardiomyopathy

Arrhythmogenic left ventricular cardiomyopathy (ALVC) is characterized by fibrofatty myocardial replacement demonstrated on cardiac magnetic resonance by late gadolinium enhancement (LGE) mainly involving the subepicardium. The aims of this study were to describe the layer-specific strain (LSS) echo...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Society of Echocardiography Vol. 37; no. 10; pp. 960 - 970
Main Authors Grimault, Dimitri, Serfaty, Jean-Michel, Guyomarch, Béatrice, Marteau, Lara, Goudal, Adeline, Schmitt, Sébastien, Warin-Fresse, Karine, Clero, Sophie, Fellah, Imen, Thollet, Aurélie, Probst, Vincent, Le Tourneau, Thierry, Trochu, Jean-Noël, Piriou, Nicolas
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Arrhythmogenic left ventricular cardiomyopathy (ALVC) is characterized by fibrofatty myocardial replacement demonstrated on cardiac magnetic resonance by late gadolinium enhancement (LGE) mainly involving the subepicardium. The aims of this study were to describe the layer-specific strain (LSS) echocardiography phenotype of ALVC and to compare it with LGE features. All consecutive ALVC pathogenic genetic variant carriers and noncarrier relatives were separated into four prespecified groups (overt ALVC [group 1], isolated LGE [group 2], pathogenic genetic variant carrier without ALVC phenotype [group 3], and no genetic variant carrier [group 4]) and studied accordingly using cardiac magnetic resonance and LSS echocardiography. Eighty-five individuals were included. Endocardial global longitudinal strain (GLS)–epicardial GLS (GLSepi) gradient was altered predominantly in group 1, illustrating transmural strain alteration in overt ALVC (3.8 ± 1.1 in group 1, 4.3 ± 2.2 in group 2, 5.2 ± 1.2 in group 3, and 5.4 ± 1.6 in group 4; P = .0017), whereas GLSepi was impaired predominantly in group 2 (endocardial GLS and GLSepi were 15.0 ± 4.1% and 11.2 ± 3.3%, respectively, in group 1; 20.5 ± 2.8% and 16.2 ± 5.5% in group 2; 23.4 ± 3.3% and 18.2 ± 2.7% in group 3; and 24.6 ± 2.8% and 19.2 ± 1.9% in group 4; P < .0001 for all). GLSepi was able to detect subepicardial LGE in genetic variant carriers without overt ALVC with an area under curve of 0.84 (95% CI, 0.73-0.95). However, segmental epicardial and endocardial strain behaved similarly and showed comparable diagnostic values for segmental LGE detection (areas under the curve, 0.72; [95% CI, 0.69-0.76] and 0.73 [95% CI, 0.70-0.76], respectively, P = .40). LSS alteration in ALVC progresses from the epicardium to the endocardium along with disease severity. Irrespective of LSS analysis, which did not provide incremental diagnostic value for the detection and localization of LGE, strain echocardiography was shown to be a potential surrogate marker of LGE, including in apparently healthy individuals with isolated LV fibrosis. Central IllustrationLSS echocardiography phenotypes of ALVC and corresponding LGE features on CMR. Pathogenic genetic ALVC variant carrier phenotypes were explored using LSS echocardiography. Patients with overt ALVC (group 1) exhibited LV global systolic dysfunction with transmural strain alteration and mechanical dispersion associated with extensive LGE on CMR. Group 2 patients had normal LV function and no mechanical dispersion but isolated subepicardial LGE on CMR and strain alteration on echocardiography, notably epicardial strain. Group 3 patients had normal LV function and no LGE, and strain parameters did not significantly differ from those of healthy relatives without pathogenic genetic variant, but regional alteration of inferior epicardial strain was suggestive of early myocardial remodeling. [Display omitted] •ALVC is a fibrotic disease.•Subepicardial LGE is the major phenotypic trait.•LSS alters along with LGE extent and LV dysfunction.•Strain echocardiography is a potential surrogate marker of LV fibrosis in ALVC.•LSS does not provide incremental diagnostic value for LGE detection and localization.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0894-7317
1097-6795
1097-6795
DOI:10.1016/j.echo.2024.05.017